Dana-Farber Cancer Institute: Gastrointestinal Neoplasms trials

The registry lists 12 Gastrointestinal Neoplasms studies with Dana-Farber Cancer Institute as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 2No phase 9(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• BOLSTER: Learning New Skills to ThriveRecruitingNCT06936878Not applicable
• Resilience and Equity in Aging, Cancer, and Health (REACH)RecruitingNCT04674267Not applicable
• Cabozantinib and Nivolumab for Carcinoid TumorsCompletedNCT04197310Phase 2Results posted
• Symptom Management Implementation of Patient Reported Outcomes in OncologyCompletedNCT03850912Not applicableResults posted
• BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and RenewalCompletedNCT03367247Not applicableResults posted
• RAD001 and AV-951 in Patients With Refractory, Metastatic Colorectal CancerCompletedNCT01058655Phase 1/2Results posted
• Vitamin D for ChemopreventionCompletedNCT00585637Phase 1Results posted
• Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)Active, not recruitingNCT05629065Not applicable
• Routine Evaluation of the Social Determinants of Health in Oncology: User-centered Resource Coordination and EngagementCompletedNCT04879927Not applicable
• EHR-embedded OCDT in Breast or GI CancerCompletedNCT03858712Not applicable
• The GI Binder: A Psychoeducational Intervention for Gastrointestinal Cancer PatientsCompletedNCT03576872Not applicable
• Physical Activity In Gastrointestinal CancerCompletedNCT03331406Not applicable